NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Also, it seems the Europeans are getting ready to ditch lomustine rGBM treatment. Here, even our old “acquaintance,” Dr. Weller, suggests not much evidence for lomustine efficacy, and where there is some evidence, it is only in combination with a couple other drugs and only in idh mutant w/ mgmt methylated. (Note: We recently learned that idh mutant is no longer considered GBM).

May 2020 online

https://www.sciencedirect.com/science/article/pii/S0305737220300670

This, and the recent removal of Lomustine in the states from Medicare for GBM are tell tale signs it’s going to fade away globally (regarding rGBM), imo.

MW also was one of those to recently suggest European Neuro-oncologists EANO already recognize the new definition for GBM — which now excludes idh mutant.

Net net, a pathway for a new (yet unannounced) GBM SOC is being made way here and abroad, imo.